PTAB challenges

Here is a detailed analysis of the post-grant proceedings for U.S. Patent No. 6,628,629.

Proceedings Overview

There has been one Inter Partes Review (IPR) filed against U.S. Patent No. 6,628,629. This proceeding did not result in a final validity decision on the merits because the parties settled and the case was terminated. Consequently, the patent's claims were not invalidated by the Patent Trial and Appeal Board (PTAB), but they also did not endure the full scrutiny of an IPR trial, leaving their validity open to future challenges with the same or different prior art.

IPR2018-00727 — Unified Patents, LLC v. Intellectual Ventures I LLC

• Type: Inter Partes Review (IPR)
• Filed: 2018-02-14
• Status: Terminated (Settled) on 2018-09-04. The proceeding concluded before a Final Written Decision was issued.
• Judge Panel: Jameson, B. L., Bisk, S. J., and Turner, M. P.
• Petition Grounds: The petition challenged claims 1-5, 8, 10-14, 17, and 19-21 of the '629 patent as unpatentable under 35 U.S.C. § 103 (obviousness) over various combinations of prior art references. The primary references included:
  • Ghosh et al., U.S. Patent No. 6,560,230 (“Ghosh”)
  • Boutros et al., U.S. Patent No. 6,647,015 (“Boutros”)
  • Bonomi et al., U.S. Patent No. 6,363,056 (“Bonomi”)
  • Jang, “Supporting and a Novel MAC Protocol for Real-Time Wireless LANs” (May 1998) (“Jang”)
• Institution Decision: The PTAB instituted trial on August 23, 2018, for all challenged claims (1-5, 8, 10-14, 17, and 19-21), finding that the Petitioner, Unified Patents, had "established a reasonable likelihood that it would prevail with respect to at least one of the claims challenged." This indicates the Board saw initial merit in the invalidity arguments.
• Final Written Decision: No Final Written Decision was issued. The proceeding was terminated before a final determination on patentability was made.
• Settlement / Termination: The parties filed a joint motion to terminate the proceeding on August 31, 2018, stating they had resolved the matter between them. The PTAB granted the motion and terminated the IPR on September 4, 2018. The terms of the settlement were not publicly disclosed.
• Appeal: There was no appeal to the U.S. Court of Appeals for the Federal Circuit (CAFC) as the IPR was terminated prior to a final decision.
• Defensive Value: The IPR petition and the Board's decision to institute provide a strong starting point for a defendant. The fact that the Board found a "reasonable likelihood" of invalidity for all challenged claims suggests the prior art arguments are substantial. Since the case settled, no statutory estoppel applies, meaning a new challenger is free to use the same grounds and prior art in a future IPR or in district court litigation. The petition itself serves as a ready-made invalidity contention.

Strategic Summary

The single IPR against the '629 patent, IPR2018-00727, targeted a broad set of claims (1-5, 8, 10-14, 17, and 19-21) but was terminated due to a settlement between Unified Patents and Intellectual Ventures I LLC. As a result, none of the claims have been formally canceled or confirmed by the PTAB. All claims of U.S. Patent No. 6,628,629 therefore remain valid and enforceable, but they are also vulnerable to future challenges.

Because the IPR was terminated pre-institution, no statutory estoppel under 35 U.S.C. § 315(e)(2) applies to Unified Patents or any other party. A new defendant is completely unencumbered by the prior proceeding and can re-use the exact same invalidity arguments and prior art references cited in the IPR2018-00727 petition. The arguments in that petition were strong enough to convince the PTAB to institute trial, which is a significant signal of the patent's potential weakness. The involvement of Unified Patents, a known defensive patent aggregator, suggests the patent was being asserted at the time, and the settlement likely involved a licensing agreement.

Recommended Next Steps

• For a defendant facing a new assertion of this patent: The petition and institution decision in IPR2018-00727 should be the first documents you review. They provide a well-researched and Board-vetted roadmap for an invalidity defense based on obviousness.
  • PTAB Institution Decision (IPR2018-00727): https://ptab.uspto.gov/06-25-2018/IPR2018-00727_Institution_Decision.pdf
  • PTAB Termination Decision (IPR2018-00727): https://ptab.uspto.gov/09-04-2018/IPR2018-00727_Termination.pdf
• Since the patent expired on July 9, 2019 (20 years from its filing date of July 9, 1999), any litigation would be for past damages only. The lack of a conclusive PTAB decision and the patent's expiration may significantly reduce its perceived value and the patent owner's leverage in licensing negotiations.
• There are no active proceedings. The key takeaway is the history of the settled IPR, which provides a strong prior art-based defense against any remaining claims for past infringement.